Melanoma Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Melanoma Information Center has current, evidence-based information for you. Get the facts about melanoma prevention, early detection, treatment, and survivorship, and stay up to date with ongoing melanoma research that could impact your treatment decisions through our daily cancer news.
You are not alone—join us in our safe and private online community for support and inspiration, and share your experience with thousands of other individuals who have been affected by melanoma. Join the discussion now to share your story and to learn how others like you have dealt with diagnosis, treatment decisions, side effects, living with metastatic disease, caregiving, and survivorship. Login or register here.
People who follow the diet and lifestyle recommendations laid out by the WCRF and the AICR have a 20 percent reduced risk of dying from cancer. Lymphoseek Approved for Detecting Lymph Nodes in Breast Cancer and Melanoma
The FDA has approved Lymphoseek to help locate lymph nodes in patients with breast cancer and melanoma. Aspirin Reduces Risk of Melanoma in Women
Women who regularly take aspirin have a reduced risk of developing melanoma, according to the results of a study published in Cancer.
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide... Women, Fertility and Cancer
Women who confront a cancer diagnosis before beginning or completing their families...
Sean Swarner is a master of setting a goal and achieving it. So when he... Jack & Jill Late Stage Cancer Foundation
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after...
Melanoma Clinical Trials
VicalLX01-315-02 – A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7 Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects with Recurrent Metastatic Melanoma
COGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN 2b in Stage T3-T4 or N1 (microscopic) Melanoma
ECOGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN-a2b in Stage T2b No, T3a-bNo, T4a-b No, and T1-2, N1a, 2a (microscopic) Melanoma.